Annual report
4570.TEDINET S100OIQD
Period2021-04-01 → 2022-03-31
Filed2022-06-30
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 133
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥648m | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥603m | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥577m | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥781m | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥758m | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥122m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | −¥241m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | −¥243m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥311m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥679m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥156m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥49m | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥250m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥311m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥259m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥319m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥668m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥167m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥53m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥259m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | −¥319m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥1.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.8bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥2.4bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.0bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.3bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥337m | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥209m | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥508m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥604m | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥449m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥552m | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥974m | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.5bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥93m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥194m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥609m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥244m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥74m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥156m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥11m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥593m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥144m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥216m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥81m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥126m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥138m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-27.78 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-34.23 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-76 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-19.82 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-7.01 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥146.92 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥174.7 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥208.97 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥245.47 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥241.64 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 80.2% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.5% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.0% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.7% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.1% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 63 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 65 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 65 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 61 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 57 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥604m | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥532m | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥500m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥631m | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥643m | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥103m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥217m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | −¥70m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥197m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥503m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥160m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥48m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥116m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥212m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | −¥124m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | −¥219m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥547m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥179m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥64m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.0bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥2.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.9bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.2bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥279m | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥118m | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.8bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥2.1bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.0bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥495m | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥535m | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-13.27 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.52 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-62.24 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.21 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.51 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥184.61 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥197.88 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥221.41 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥244.88 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥240.37 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 86.1% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.9% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.5% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 9,314,590 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,314,590 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,314,590 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,724,590 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,333,090 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 62 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 58 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 56 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 52 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 48 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 42
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥3m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | ¥560,000 |
| Cosmeticsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥13m |
| Cosmeticsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥13m |
| Cosmeticsreportable segment | segment assets | at 2022-03-31 | ¥93m |
| Cosmeticsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥13m |
| Gene Recombination Silkworm Developmentreportable segment | segment assets | at 2022-03-31 | ¥453m |
| Gene Recombination Silkworm Developmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥95m |
| Immunity Relatedreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥637m |
| Immunity Relatedreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥634m |
| Immunity Relatedreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3m |
| Immunity Relatedreportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| Immunity Relatedreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥15m |
| —segment total | employees | at 2022-03-31 | 63 pure |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥651m |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥648m |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥3m |
| —segment total | segment assets | at 2022-03-31 | ¥1.7bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | −¥123m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥17m |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | ¥960,000 |
| Cosmeticsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥14m |
| Cosmeticsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥14m |
| Cosmeticsreportable segment | segment assets | at 2021-03-31 | ¥55m |
| Cosmeticsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥14m |
| Gene Recombination Silkworm Developmentreportable segment | segment assets | at 2021-03-31 | ¥565m |
| Gene Recombination Silkworm Developmentreportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥173m |
| Immunity Relatedreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥13m |
| Immunity Relatedreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥605m |
| Immunity Relatedreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥589m |
| Immunity Relatedreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥17m |
| Immunity Relatedreportable segment | segment assets | at 2021-03-31 | ¥1.2bn |
| Immunity Relatedreportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥55m |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥13m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥620m |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥603m |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥17m |
| —segment total | segment assets | at 2021-03-31 | ¥1.8bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | −¥242m |
| —segment total | employees | at 2022-03-31 | 62 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,233
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E00986-000CosmeticsReportableSegmentsMember | － | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_ReportableSegmentsMember | － | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration | － | JPY |
| Impairment loss el | Prior1YearDuration_jpcrp030000-asr_E00986-000ImmunityRelatedReportableSegmentMember | 118000 | JPY |
| Impairment loss el | Prior1YearDuration_jpcrp030000-asr_E00986-000GeneRecombinationSilkwormDevelopmentReportableSegmentMember | － | JPY |
| Impairment loss el | Prior1YearDuration_jpcrp030000-asr_E00986-000CosmeticsReportableSegmentsMember | － | JPY |
| Impairment loss el | Prior1YearDuration_ReportableSegmentsMember | 118000 | JPY |
| Impairment loss el | CurrentYearDuration_jpcrp030000-asr_E00986-000ImmunityRelatedReportableSegmentMember | 7041000 | JPY |
| Impairment loss el | CurrentYearDuration_jpcrp030000-asr_E00986-000GeneRecombinationSilkwormDevelopmentReportableSegmentMember | － | JPY |
| Impairment loss el | CurrentYearDuration_jpcrp030000-asr_E00986-000CosmeticsReportableSegmentsMember | － | JPY |
| Impairment loss el | CurrentYearDuration_ReportableSegmentsMember | 7041000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 534757000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 494995000 | JPY |
| Notes receivable trade | Prior1YearInstant_NonConsolidatedMember | 29868000 | JPY |
| Notes receivable trade | CurrentYearInstant_NonConsolidatedMember | 32065000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 155722000 | JPY |
| Accounts receivable trade | CurrentYearInstant_NonConsolidatedMember | 141046000 | JPY |
| Merchandise and finished goods | Prior1YearInstant_NonConsolidatedMember | 24149000 | JPY |
| Merchandise and finished goods | CurrentYearInstant_NonConsolidatedMember | 26340000 | JPY |
| Work in process | Prior1YearInstant_NonConsolidatedMember | 132713000 | JPY |
| Work in process | CurrentYearInstant_NonConsolidatedMember | 133314000 | JPY |
| Raw materials and supplies | Prior1YearInstant_NonConsolidatedMember | 97662000 | JPY |
| Raw materials and supplies | CurrentYearInstant_NonConsolidatedMember | 123956000 | JPY |
| Short term loans receivable | Prior1YearInstant_NonConsolidatedMember | － | JPY |
| Short term loans receivable | CurrentYearInstant_NonConsolidatedMember | 30000000 | JPY |
| Current portion of long term loans receivable from subsidiaries and affiliates | Prior1YearInstant_NonConsolidatedMember | － | JPY |
| Current portion of long term loans receivable from subsidiaries and affiliates | CurrentYearInstant_NonConsolidatedMember | 120000000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 8762000 | JPY |
| Other ca | CurrentYearInstant_NonConsolidatedMember | 6978000 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 983635000 | JPY |
| Current assets | CurrentYearInstant_NonConsolidatedMember | 1108698000 | JPY |
| Land | Prior1YearInstant_NonConsolidatedMember | 127122000 | JPY |
| Land | CurrentYearInstant_NonConsolidatedMember | 120081000 | JPY |
| Property plant and equipment | Prior1YearInstant_NonConsolidatedMember | 127122000 | JPY |
| Property plant and equipment | CurrentYearInstant_NonConsolidatedMember | 120081000 | JPY |
| Investment securities | Prior1YearInstant_NonConsolidatedMember | 24384000 | JPY |
| Investment securities | CurrentYearInstant_NonConsolidatedMember | 24384000 | JPY |
| Stocks of subsidiaries and affiliates | Prior1YearInstant_NonConsolidatedMember | 751043000 | JPY |
| Stocks of subsidiaries and affiliates | CurrentYearInstant_NonConsolidatedMember | 688000000 | JPY |
| Long term loans receivable from subsidiaries and affiliates | Prior1YearInstant_NonConsolidatedMember | 90000000 | JPY |
| Long term loans receivable from subsidiaries and affiliates | CurrentYearInstant_NonConsolidatedMember | 100000000 | JPY |
| Long term prepaid expenses | Prior1YearInstant_NonConsolidatedMember | 648000 | JPY |
| Long term prepaid expenses | CurrentYearInstant_NonConsolidatedMember | 1266000 | JPY |
| Insurance funds | Prior1YearInstant_NonConsolidatedMember | 50926000 | JPY |
| Insurance funds | CurrentYearInstant_NonConsolidatedMember | 35189000 | JPY |
| Other ioa | Prior1YearInstant_NonConsolidatedMember | 18703000 | JPY |
| Other ioa | CurrentYearInstant_NonConsolidatedMember | 17728000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant_NonConsolidatedMember | -83562000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentYearInstant_NonConsolidatedMember | -97405000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |